ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 4 of 88 for:    Recruiting, Not yet recruiting Studies | psychotherapy

Meaning-Centered Psychotherapy Training for Cancer Care Providers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02730039
Recruitment Status : Recruiting
First Posted : April 6, 2016
Last Update Posted : June 8, 2018
Sponsor:
Collaborators:
Stanford University
Northwestern University
MJHS Institute For Innovation in Palliative Care
Massachusetts General Hospital
City of Hope Medical Center
Dana-Farber Cancer Institute
New York Presbyterian Hospital
Odette Cancer Center – Sunnybrook Hospital
VA New York Harbor Healthcare System
University of Pennsylvania
Smilow Cancer Hospital – Yale New Haven Health
Veterans Affairs of New Jersey
Vidant Cancer Care
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

Brief Summary:
The purpose of this project, entitled "Meaning-Centered Psychotherapy Training for Cancer Care Providers," is to develop a multi-modal training program in Meaning-Centered Psychotherapy (MCP) for multidisciplinary cancer care clinicians who provide psycho-oncology and psychosocial palliative care services for cancer patients.

Condition or disease Intervention/treatment
Cancer Care Providers Behavioral: workshop Behavioral: follow-up calls & webinars Behavioral: assessments

Study Type : Observational
Estimated Enrollment : 350 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Meaning-Centered Psychotherapy Training for Cancer Care Providers
Actual Study Start Date : December 11, 2015
Estimated Primary Completion Date : December 11, 2020
Estimated Study Completion Date : December 11, 2020

Group/Cohort Intervention/treatment
Cancer Care Providers

Provider will attend a MCPT two-day intensive workshop that will include:

  • Didactic Components
  • Experiential Exercises
  • Simulated patient role plays with actors
  • Provider completes MCPT Workshop Assessment MCPT POST-WORKSHOP IMPLEMTATION (OPTIONAL)
  • MCP Core Competency Trainer rated Assessment
  • MCP Pre & Post Workshop Knowledge Assessment
  • MCPT Session Evaluation Assessment Provider will participate in training follow-up calls & webinars for approximately 6 -12 months following completion of MCPT workshop.
  • Provider will have ongoing access to MCPT Website with a discussion board, training resources and materials for clinical care.
  • Provider will complete follow-up assessment at 3, 6, 9, & 12 months post-training
  • Training Update
  • Goal Evaluation Form
  • MCP Core Competency Self-Assessment MCPT POST-WORKSHOP IMPLEMTATION (OPTIONAL)
Behavioral: workshop
Behavioral: follow-up calls & webinars
Behavioral: assessments



Primary Outcome Measures :
  1. participant's skills uptake at the end of the MCPT session score range 0-10 [ Time Frame: change from Baseline to 12 months ]
    Evaluation will take place on two levels, as data will be collected directly from: 1) MCPT participants and 2) MCP trainers. Data on the training will be collected before and during the MCPT session. Data on post-MCP training will be collected for one year following participation in the MCPT.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   21 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
clinicians (20% MSKCC providers & 80% outside providers)
Criteria

Inclusion Criteria:

  • Clinicians who provide psycho-oncology and/or psychosocial palliative care services for to patients with cancer and/or severe medical illness/disease at MSKCC, other institutions, or in the community, as per self-report.
  • Completed online MCPT application form and commits to attend the two-day intensive MCPT program, complete training follow-up assessments, and participate in required follow-up training activities.
  • Able to speak, read, and understand English proficiently to participate in MCPT training sessions and complete assessments.

Exclusion Criteria:

  • Does not meet the criteria of an appropriate candidate for training program, as determined by review of the MCPT Application Evaluation Checklist in the opinion of the investigator.

    • Materials for the training and the training will be conducted in English only.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02730039


Contacts
Contact: William Breitbart, MD 646-888-0020
Contact: Katherine DuHamel, PhD 646-888-0032

Locations
United States, New York
Memorial Sloan Kettering Cancer Center Recruiting
New York, New York, United States, 10065
Contact: William Breitbart, MD    646-888-0020      
Contact: Katherine DuHamel, PhD    646-888-0032      
Principal Investigator: William Breitbart, MD         
Sponsors and Collaborators
Memorial Sloan Kettering Cancer Center
Stanford University
Northwestern University
MJHS Institute For Innovation in Palliative Care
Massachusetts General Hospital
City of Hope Medical Center
Dana-Farber Cancer Institute
New York Presbyterian Hospital
Odette Cancer Center – Sunnybrook Hospital
VA New York Harbor Healthcare System
University of Pennsylvania
Smilow Cancer Hospital – Yale New Haven Health
Veterans Affairs of New Jersey
Vidant Cancer Care
Investigators
Principal Investigator: William Breitbart, MD Memorial Sloan Kettering Cancer Center

Additional Information:
Responsible Party: Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT02730039     History of Changes
Other Study ID Numbers: 15-321
First Posted: April 6, 2016    Key Record Dates
Last Update Posted: June 8, 2018
Last Verified: June 2018

Keywords provided by Memorial Sloan Kettering Cancer Center:
Cancer Care Providers
Psychotherapy
15-321